Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

每周两次进行结核化疗治疗.

L D Hudson, J A Sbarbaro

    JAMA
    |January 8, 1973
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Nasogastric tube feeding in line with new dietetic guidelines for the treatment of anorexia nervosa in a specialist children and adolescent inpatient unit: a case series.

    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2020
    Same author

    Bone mineral density in Anorexia Nervosa versus Avoidant Restrictive Food Intake Disorder.

    Bone·2020
    Same author

    Arterial stiffening, insulin resistance and acanthosis nigricans in a community sample of adolescents with obesity.

    International journal of obesity (2005)·2017
    Same author

    Alterations in neuronal gene expression profiles in response to experimental demyelination and axonal transection.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2010
    Same author

    Long-term outcomes after ARDS.

    Seminars in respiratory and critical care medicine·2005
    Same author

    Cytokine balance in the lungs of patients with acute respiratory distress syndrome.

    American journal of respiratory and critical care medicine·2001
    Same journal

    Online Prescribing of GLP-1 Receptor Agonists.

    JAMA·2026
    Same journal

    Using AI Disagreement to Expose Gaps in Coverage Rules.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy.

    JAMA·2026
    Same journal

    Randomized Trials in Pregnancy-Reply.

    JAMA·2026
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    查看所有相关文章